IFNA1 and systemic lupus erythematosus: Therefore, though type I IFN is observed to be elevated in association with antibody positivity prior to SLE diagnosis, type II IFN and IFN-associated mediators seem to represent the pathogenetic intermediaries altering innate and adaptive immune system derangements through elevation of IFN-α and autoantibody formation.